• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ASXL2通过将雌激素受体α(ERα)与组蛋白甲基化联系起来促进乳腺癌细胞增殖。

ASXL2 promotes proliferation of breast cancer cells by linking ERα to histone methylation.

作者信息

Park U-H, Kang M-R, Kim E-J, Kwon Y-S, Hur W, Yoon S K, Song B-J, Park J H, Hwang J-T, Jeong J-C, Um S-J

机构信息

Department of Bioscience and Biotechnology, Sejong University, Seoul, Korea.

Bioevaluation Center, Korea Research Institute of Bioscience and Biotechnology, Ochang, Cheongwon, Korea.

出版信息

Oncogene. 2016 Jul 14;35(28):3742-52. doi: 10.1038/onc.2015.443. Epub 2015 Dec 7.

DOI:10.1038/onc.2015.443
PMID:26640146
Abstract

Estrogen receptor alpha (ERα) has a pivotal role in breast carcinogenesis by associating with various cellular factors. Selective expression of additional sex comb-like 2 (ASXL2) in ERα-positive breast cancer cells prompted us to investigate its role in chromatin modification required for ERα activation and breast carcinogenesis. Here, we observed that ASXL2 interacts with ligand E2-bound ERα and mediates ERα activation. Chromatin immunoprecipitation-sequencing analysis supports a positive role of ASXL2 at ERα target gene promoters. ASXL2 forms a complex with histone methylation modifiers including LSD1, UTX and MLL2, which all are recruited to the E2-responsive genes via ASXL2 and regulate methylations at histone H3 lysine 4, 9 and 27. The preferential binding of the PHD finger of ASXL2 to the dimethylated H3 lysine 4 may account for its requirement for ERα activation. On ASXL2 depletion, the proliferative potential of MCF7 cells and tumor size of xenograft mice decreased. Together with our finding on the higher ASXL2 expression in ERα-positive patients, we propose that ASXL2 could be a novel prognostic marker in breast cancer.

摘要

雌激素受体α(ERα)通过与多种细胞因子相互作用在乳腺癌发生过程中起关键作用。额外性梳状蛋白样2(ASXL2)在ERα阳性乳腺癌细胞中的选择性表达促使我们研究其在ERα激活和乳腺癌发生所需的染色质修饰中的作用。在此,我们观察到ASXL2与配体E2结合的ERα相互作用并介导ERα激活。染色质免疫沉淀测序分析支持ASXL2在ERα靶基因启动子处的积极作用。ASXL2与包括LSD1、UTX和MLL2在内的组蛋白甲基化修饰因子形成复合物,这些因子均通过ASXL2被招募到E2反应基因并调节组蛋白H3赖氨酸4、9和27处的甲基化。ASXL2的PHD结构域与二甲基化的H3赖氨酸4的优先结合可能解释了其对ERα激活的需求。在ASXL2缺失时,MCF7细胞的增殖潜能和异种移植小鼠的肿瘤大小减小。结合我们在ERα阳性患者中发现的ASXL2高表达情况,我们提出ASXL2可能是乳腺癌中的一种新型预后标志物。

相似文献

1
ASXL2 promotes proliferation of breast cancer cells by linking ERα to histone methylation.ASXL2通过将雌激素受体α(ERα)与组蛋白甲基化联系起来促进乳腺癌细胞增殖。
Oncogene. 2016 Jul 14;35(28):3742-52. doi: 10.1038/onc.2015.443. Epub 2015 Dec 7.
2
An H3K4me3 reader, BAP18 as an adaptor of COMPASS-like core subunits co-activates ERα action and associates with the sensitivity of antiestrogen in breast cancer.一种 H3K4me3 阅读器,BAP18 作为 COMPASS 样核心亚基的接头,共同激活 ERα 作用,并与乳腺癌中抗雌激素的敏感性相关。
Nucleic Acids Res. 2020 Nov 4;48(19):10768-10784. doi: 10.1093/nar/gkaa787.
3
Regulation of estrogen receptor α by histone methyltransferase SMYD2-mediated protein methylation.组蛋白甲基转移酶 SMYD2 通过蛋白质甲基化调节雌激素受体 α。
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17284-9. doi: 10.1073/pnas.1307959110. Epub 2013 Oct 7.
4
A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.增强子结合的CARM1利用的一种高甲基化策略,以促进雌激素受体α依赖性转录激活和乳腺癌发生。
Theranostics. 2020 Feb 10;10(8):3451-3473. doi: 10.7150/thno.39241. eCollection 2020.
5
Anticipatory estrogen activation of the unfolded protein response is linked to cell proliferation and poor survival in estrogen receptor α-positive breast cancer.未折叠蛋白反应的预期性雌激素激活与雌激素受体α阳性乳腺癌的细胞增殖及不良预后相关。
Oncogene. 2015 Jul;34(29):3760-9. doi: 10.1038/onc.2014.292. Epub 2014 Sep 29.
6
Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.雌激素受体-β对调节乳腺癌中基因表达、增殖和凋亡的ERα-p53环路的调控
Horm Cancer. 2017 Aug;8(4):230-242. doi: 10.1007/s12672-017-0298-1. Epub 2017 Jun 2.
7
PELP1 oncogenic functions involve CARM1 regulation.PELP1 的致癌功能涉及 CARM1 的调节。
Carcinogenesis. 2013 Jul;34(7):1468-75. doi: 10.1093/carcin/bgt091. Epub 2013 Mar 13.
8
UTX and MLL4 coordinately regulate transcriptional programs for cell proliferation and invasiveness in breast cancer cells.UTX 和 MLL4 协调调节乳腺癌细胞中细胞增殖和侵袭的转录程序。
Cancer Res. 2014 Mar 15;74(6):1705-17. doi: 10.1158/0008-5472.CAN-13-1896. Epub 2014 Feb 3.
9
Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis.组蛋白去甲基化酶 JMJD2B 协调 H3K4/H3K9 甲基化,促进激素反应性乳腺癌发生。
Proc Natl Acad Sci U S A. 2011 May 3;108(18):7541-6. doi: 10.1073/pnas.1017374108. Epub 2011 Apr 18.
10
Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells.表观遗传失调的 microRNA-375 与乳腺癌细胞中的雌激素受体α形成正反馈回路。
Cancer Res. 2010 Nov 15;70(22):9175-84. doi: 10.1158/0008-5472.CAN-10-1318. Epub 2010 Oct 26.

引用本文的文献

1
Asxl1 loss in mice leads to microcephaly by regulating neural stem cell survival.小鼠中Asxl1基因缺失通过调节神经干细胞存活导致小头畸形。
Anim Cells Syst (Seoul). 2025 Apr 23;29(1):241-250. doi: 10.1080/19768354.2025.2481979. eCollection 2025.
2
An epigenetic pathway regulates MHC-II expression and function in B cell lymphoma models.在B细胞淋巴瘤模型中,一种表观遗传途径调节MHC-II的表达和功能。
J Clin Invest. 2025 Jan 16;135(2):e179703. doi: 10.1172/JCI179703.
3
Integrative analysis of ASXL family genes reveals ASXL2 as an immunoregulatory molecule in head and neck squamous cell carcinoma.

本文引用的文献

1
Additional sex combs-like 2 is required for polycomb repressive complex 2 binding at select targets.额外的性梳状结构 2 对于多梳抑制复合物 2 在特定靶标上的结合是必需的。
PLoS One. 2013 Sep 9;8(9):e73983. doi: 10.1371/journal.pone.0073983. eCollection 2013.
2
Functional and cancer genomics of ASXL family members.ASXL 家族成员的功能和癌症基因组学。
Br J Cancer. 2013 Jul 23;109(2):299-306. doi: 10.1038/bjc.2013.281. Epub 2013 Jun 4.
3
The histone demethylase PHF8 governs retinoic acid response in acute promyelocytic leukemia.
ASXL家族基因的综合分析揭示ASXL2是头颈部鳞状细胞癌中的一种免疫调节分子。
Sci Rep. 2024 Dec 28;14(1):31368. doi: 10.1038/s41598-024-82815-8.
4
Addressing the mean-variance relationship in spatially resolved transcriptomics data with .用……处理空间转录组学数据中的均值-方差关系
bioRxiv. 2024 Nov 8:2024.11.04.621867. doi: 10.1101/2024.11.04.621867.
5
Placental co-transcriptional activator Vestigial-like 1 (VGLL1) drives tumorigenesis via increasing transcription of proliferation and invasion genes.胎盘共转录激活因子类原基蛋白1(VGLL1)通过增加增殖和侵袭基因的转录来驱动肿瘤发生。
Front Oncol. 2024 Jun 7;14:1403052. doi: 10.3389/fonc.2024.1403052. eCollection 2024.
6
Additional Sex Combs-like Family Associated with Epigenetic Regulation.额外的性梳家族与表观遗传调控有关。
Int J Mol Sci. 2024 May 8;25(10):5119. doi: 10.3390/ijms25105119.
7
H4K20me3, H3K4me2 and H3K9me2 mediate the effect of ER on prognosis in breast cancer.H4K20me3、H3K4me2和H3K9me2介导雌激素受体对乳腺癌预后的影响。
Epigenetics. 2024 Dec;19(1):2343593. doi: 10.1080/15592294.2024.2343593. Epub 2024 Apr 21.
8
Shikonin Binds and Represses PPARγ Activity by Releasing Coactivators and Modulating Histone Methylation Codes.紫草素通过释放共激活因子和调节组蛋白甲基化密码来结合并抑制 PPARγ 活性。
Nutrients. 2023 Apr 6;15(7):1797. doi: 10.3390/nu15071797.
9
Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond.乳腺癌中的组蛋白修饰及靶向组蛋白修饰的抗癌药物:基础与拓展
Front Pharmacol. 2022 Sep 15;13:946811. doi: 10.3389/fphar.2022.946811. eCollection 2022.
10
A state-of-the-art review on LSD1 and its inhibitors in breast cancer: Molecular mechanisms and therapeutic significance.关于 LSD1 及其抑制剂在乳腺癌中的研究现状综述:分子机制与治疗意义
Front Pharmacol. 2022 Sep 16;13:989575. doi: 10.3389/fphar.2022.989575. eCollection 2022.
组蛋白去甲基酶 PHF8 调控急性早幼粒细胞白血病中维甲酸的反应。
Cancer Cell. 2013 Mar 18;23(3):376-89. doi: 10.1016/j.ccr.2013.02.014.
4
Epigenetic regulation of estrogen signaling in breast cancer.乳腺癌中雌激素信号的表观遗传调控。
Epigenetics. 2013 Mar;8(3):237-45. doi: 10.4161/epi.23790. Epub 2013 Jan 30.
5
Expression and significance of histone H3K27 demethylases in renal cell carcinoma.组蛋白 H3K27 去甲基化酶在肾细胞癌中的表达及意义。
BMC Cancer. 2012 Oct 12;12:470. doi: 10.1186/1471-2407-12-470.
6
Maintenance of adult cardiac function requires the chromatin factor Asxl2.成年心脏功能的维持需要染色质因子 Asxl2。
J Mol Cell Cardiol. 2012 Nov;53(5):734-41. doi: 10.1016/j.yjmcc.2012.08.014. Epub 2012 Aug 27.
7
Elevated expression of LSD1 (Lysine-specific demethylase 1) during tumour progression from pre-invasive to invasive ductal carcinoma of the breast.在乳腺从非浸润性癌进展为浸润性导管癌的过程中,赖氨酸特异性去甲基化酶1(LSD1)的表达升高。
BMC Clin Pathol. 2012 Aug 24;12:13. doi: 10.1186/1472-6890-12-13.
8
Epigenetics as a therapeutic target in breast cancer.表观遗传学作为乳腺癌的治疗靶点。
J Mammary Gland Biol Neoplasia. 2012 Dec;17(3-4):191-204. doi: 10.1007/s10911-012-9263-3. Epub 2012 Jul 27.
9
Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer.靶向PELP1-KDM1轴作为乳腺癌的一种潜在治疗策略。
Breast Cancer Res. 2012 Jul 19;14(4):R108. doi: 10.1186/bcr3229.
10
Lysine-specific histone demethylase 1 inhibitors control breast cancer proliferation in ERα-dependent and -independent manners.赖氨酸特异性组蛋白去甲基酶 1 抑制剂以依赖和不依赖 ERα 的方式控制乳腺癌增殖。
ACS Chem Biol. 2012 Jul 20;7(7):1221-31. doi: 10.1021/cb300108c. Epub 2012 May 10.